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Helicobacter pylori (HP) is a Gram‐negative bacterium that chronically infects the
stomach of more than 50% of human population and represents a major cause of gas-
tric cancer, gastric lymphoma, gastric autoimmunity, and peptic ulcer. It still remains to
be elucidated, which HP virulence factors are important in the development of gastric
disorders. Here, we analysed the role of the HP protein HP1454 in the host–pathogen
interaction. We found that a significant proportion of T cells isolated from HP patients
with chronic gastritis and gastric adenocarcinoma proliferated in response to HP1454.
Moreover, we demonstrated in vivo that HP1454 protein drives Th1/Th17 inflamma-
tory responses. We further analysed the in vitro response of human T cells exposed
either to an HP wild‐type strain or to a strain with a deletion of the hp1454 gene,
and we revealed that HP1454 triggers the T‐cell antigen receptor‐dependent signal-
ling and lymphocyte proliferation, as well as the CXCL12‐dependent cell adhesion
and migration. Our study findings prove that HP1454 is a crucial bacterial factor that
exerts its proinflammatory activity by directly modulating the T‐cell response. The
relevance of these results can be appreciated by considering that compelling evidence
suggest that chronic gastric inflammation, a condition that paves the way to
HP‐associated diseases, is dependent on T cells.
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Helicobacter pylori (HP) is a Gram‐negative bacterium able to colonise
the human stomach and responsible for the infection of 50% of the
worldwide population (Hooi et al., 2017; Zamani et al., 2018). It
represents a major cause of chronic, active gastritis and contributes
to the development of more severe gastric pathologies, including pep-
tic ulcer, gastric cancer, and MALT lymphoma (D'Elios, Appelmelk,
Amedei, Bergman, & Del Prete, 2004; Goodwin, 1997; Montecuccoally to this work.
wileyonlinelibrary.com/j& Rappuoli, 2001). The type of the host immune/inflammatory
response against HP is crucial for the outcome of the infection.
T lymphocytes, particularly interferon (IFN)‐γ‐secreting Th1 cells
and Th17 cells, have been proposed to play a central role in HP per-
sistent infection and in sustaining chronic inflammation (Bamford
et al., 1998; D'Elios et al., 1997; Luzza et al., 2000; Sommer et al.,
1998). The neutrophil activating protein HP‐NAP is a major antigen
of HP able to promote Th1 immune responses, by means of neutro-
phils and monocytes that release pro‐Th1 cytokines upon the expo-
sure to the protein (Amedei et al., 2006; D'Elios, Amedei, Cappon,
Del Prete, & de Bernard, 2007; Dundon, de Bernard, & Montecucco,
2001; Polenghi et al., 2007). However, the possibility that HP might© 2019 John Wiley & Sons Ltdournal/cmi 1 of 12
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never been explored. HP proteins exposed on the external surface of
the bacterium or secreted by the bacterium are the candidates for
interacting with the immune system. Among these, HP1454, a
protein of 303 amino acids, whose structure has been recently
determined (Quarantini, Cendron, & Zanotti, 2014), is particularly
interesting, and its function remains unknown. HP1454 is a secreted
protein characterized by a predicted cleavable N‐terminal signal
sequence. It has been also identified as a component of the outer
membrane vesicles (OMV), which were shown to contain mainly,
but not exclusively, outer membrane proteins (Olofsson et al.,
2010). The hp1454 gene belongs to an operon containing three
further genes (hp1455–hp1457) that encode proteins that,
similar to HP1454, are predicted to be in the OMV. Expression
of HP1454 is pH dependent (Wen, Feng, Scott, Marcus, &
Sachs, 2006).
In this study, we evaluated whether a T‐cell response towards
HP1454 develops in the gastric mucosa of HP‐positive patients with
chronic gastritis and gastric adenocarcinoma.
Moreover, in order to elucidate whether HP1454 has a role in
orchestrating the adaptive immune response induced by HP infection,
we assessed the impact of the protein on humanT lymphocytes, com-
paring bacteria or vesicles from a wild‐type (WT) strain with bacteria
or vesicles from a strain with a deletion of the hp1454 gene.
The results provide evidence that a significant proportion of T
cells in chronic gastritis and in gastric adenocarcinoma is specific for
HP1454 and that the protein is important for a full activation of T‐cell
antigen receptor (TCR) signalling, cell proliferation, and cell motility, as
well as for the differentiation of T cells towards theTh1/Th17 profiles.
Finally, we revealed that HP1454 possesses an ITIM motif that has a
key role in TCR signalling and in T‐cell activation and proliferation.2 | RESULTS
2.1 | In vivo relevance of T cells specific for HP1454
in patients with chronic gastritis and gastric
adenocarcinoma
Because the only evidence on the production of HP1454 by HP
derives from a secretome analysis performed on the bacterium
in vitro (Bumann et al., 2002), we first verified whether HP actually
releases HP1454 in infected hosts, by active secretion or following
bacteria lysis, considering the presence of protein‐specific T cells in
the gastric mucosa of HP‐infected patients, as a proxy. The in vivo
activated T cells infiltrating the gastric mucosa of eight HP‐infected
patients with uncomplicated chronic gastritis and of eight HP‐
infected patients with distal gastric adenocarcinoma were expanded
by culture in interleukin (IL)‐2‐conditioned medium for 10 days. T‐cell
blasts were recovered and cloned by limiting dilution, as reported pre-
viously (D'Elios et al., 1997). All CD4+ and CD8+ T‐cell clones
obtained from the gastric biopsies of HP‐infected patients were
tested for proliferation to a recombinant form of HP1454 in the pres-
ence of irradiated autologous antigen‐presenting cells. Fifteen (2.09%)
of the 715 CD4+ T‐cell clones obtained from uncomplicated chronicgastritis were specific for HP1454, whereas 53 (7.78%) of the 681
CD4+ T‐cell clones obtained from the gastric mucosa of patients with
gastric adenocarcinoma showed significant proliferation to HP1454
(Figure 1a). None of CD8+ clones significantly proliferated to
HP1454. Of the 15 CD4+ T‐cell clones obtained from uncomplicated
chronic gastritis, five produced IFN‐γ alone (33.3%), six produced IL‐
17 alone (40.0%), and four produced IFN‐γ together with IL‐17
(26.7%; Figure 1b). On the other side, upon stimulation with
HP1454, 16 out of 53 HP1454‐specific T‐cell clones, derived from
gastric adenocarcinoma T cells, produced IFN‐γ alone (30.19%), 12
clones produced IL‐17 alone (22.64%), and 25 produced IFN‐γ in
combination with IL‐17 (47.17%; Figure 1b). Notably, HP1454‐
specific clones from the gastric mucosa of patients with gastric ade-
nocarcinoma produced more tumour necrosis factor α (TNF‐α;
3.22 ± 1.42 ng ml−1) and IL‐17 (1.93 ± 0.85 ng ml−1), compared with
the 15 HP1454‐specific clones from the gastric mucosa of patients
with uncomplicated chronic gastritis (TNF‐α 1.1 ± 0.4 ng ml−1 and
IL‐17 1.55 ± 0.61 ng ml−1; Figure 1c).
Taken together, these results suggest that the protein HP1454 is
released by HP in infected patients, and it drivesTh1 and Th17 inflam-
matory responses during chronic HP infection and in patients with dis-
tal adenocarcinoma.2.2 | In silico analysis suggests the involvement of
HP1454 in the host–pathogen interaction
HP1454 has no significant sequence similarities with other proteins,
but it is conserved among other Helicobacter strains (Quarantini
et al., 2014), suggesting that this protein may play Helicobacter‐
specific functions. Analysis of HP1454 by INGA (Interaction Network
GO Annotator), a web server for the sequence‐based prediction of
protein function (Piovesan, Giollo, Leonardi, Ferrari, & Tosatto,
2015), predicts that this protein is a lipid‐binding protein that localizes
in the outer membrane (Figure S1A). Accordingly, HP1454 includes an
N‐terminal LPP20 lipoprotein motif (Pfam: PF02169) that is character-
istic of a non‐essential class of lipoproteins thought to act as inflam-
matory mediators (Vallese et al., 2017). A further analysis with
FELLS, a server for the prediction of secondary structure, disorder,
aggregation, and sequence complexity of a protein, revealed an
extended hydrophobic cluster between residues 96 and 201. Addi-
tionally, two short disordered segments between residues 75–90
and 282–303 are predicted. A large hydrophobic cluster is expected
in a lipid binding protein, whereas short disordered segments, typically
of five to eight residues, are efficient antigens (Xie et al., 2007).
Indeed, it was demonstrated that specific linear motifs residing in
short intrinsically disordered segments are able to modulate the
immune response (Uversky, Oldfield, & Dunker, 2005). Inspection of
the database for the identification of eukaryotic linear motif ELM
(Dinkel et al., 2016) shows the presence of a putative immunoreceptor
tyrosine‐based motif (ITAM/ITIM) within the disordered region at the
HP1454 C‐terminus (LIG_TYR_ITIM residues 284–289). A second
ITAM/ITIM motif was also found in positions 112–117, but it localizes
in a β‐sheet forming region, thus suggesting that it may be a false pos-
itive (Figure S1B). An example of immunogenic modulation mediated
FIGURE 1 HP1454 drives Th1 and Th17 inflammatory responses during chronic Helicobacter pylori (HP) infection in vivo. (a) Percentage of
proliferating CD4+ T‐cell clones, obtained from the gastric mucosa of patients with gastric adenocarcinoma (n = 53) or from patients with
uncomplicated chronic gastritis (n = 15), in response to HP1454. (b,c) HP1454‐specific gastric CD4+ T‐cell clones derived from patients with distal
gastric adenocarcinoma or with chronic gastritis were tested for cytokine production. HP1454‐specific CD4+ T‐cell clones were stimulated with
HP1454 and autologous antigen‐presenting cells for 48 hr, and cytokine production was measured in culture supernatants. Clones producing
interferon (IFN)‐γ/tumour necrosis factor (TNF)‐α are named Th1, those producing interleukin (IL)‐17 as Th17, and those producing IFN‐γ/TNF‐α
and IL‐17 are named Th17/Th17. In unstimulated cultures, levels of TNF‐α, IFN‐γ, and IL‐17 were consistently <20 pg ml−1. Error bars, SD.
***p ≤ 0.001; *p ≤ 0.05
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enteropathogenic Escherichia coli proteins Tir, which was found to
inhibit toll‐like receptor (TLR) signalling by recruiting the phosphatase
SHP‐1 to the activated receptor (Yan, Wang, Luo, Cao, & Ge, 2012).
This finding, taken together with the presence of a LPP20 lipoprotein
motif, suggests that HP1454 can be an immune modulator in the con-
text of the interaction between human and HP.
2.3 | HP1454 localization in the OMVs
To confirm the localization of HP1454 in OMV, ultrathin sections of
purified OMV were incubated with a polyclonal antibody against
HP1454 followed by a gold conjugated anti‐rabbit IgG. Immunogold
images show the presence of HP1454 protein associated with the
membrane of vesicles purified from an HP broth culture at the early
stationary phase (Figure S2A).
2.4 | HP1454 is required for the TCR‐dependent
signalling in T cells exposed to HP
To assess the role of HP1454 protein in the activation of T lympho-
cytes, primary T cells, purified from peripheral blood of healthydonors, were cultured in vitro with either HP WT or HP KO or
exposed to either OMV WT or OMV KO. Control cells were not
exposed to bacteria or to OMV. In addition, to assess whether the
effect of HP1454 on T lymphocytes could rely on the ITIM motif, we
produced a mutant in the conserved tyrosine (Tyr286 ➔ Phe;
Verbrugge, Ruiter Td, de Clevers, & Meyaard, 2003; Vuyyuru, Shen,
& Manser, 2015) and compared the activation of T lymphocytes
exposed to the recombinant protein HP1454 WT with that elicited
by the mutated protein (HP1454 mut).
After a 24‐hr incubation with HP, OMV, or recombinant protein
HP1454, either WT or mutated, cells were stimulated with an ago-
nistic anti‐CD3 monoclonal antibody and the expression level of
the activation marker CD69 was determined by flow cytometry. As
shown in Figure 2a, infection of T lymphocytes reduced by 50%
the expression of CD69 compared with control cells, in accordance
with previous evidence (Boncristiano et al., 2003). However, it is
noteworthy that the expression of the activation marker was further
downregulated in lymphocytes cultured with HP KO or exposed to
OMV KO compared with WT counterparts. Similar to WT HP, treat-
ment with the recombinant protein HP1454 WT induced high levels
of CD69 surface expression, whereas a significant reduction in CD69
surface levels was observed when cells were treated with the
FIGURE 2 HP1454 positively regulates T‐cell activation. (a) Expression of CD69 on purified peripheral T cells from six healthy donors cultured
with Helicobacter pylori (HP), outer membrane vesicles (OMV), and HP1454, either wild‐type (WT) or mutant, for 24 hr, and then stimulated with
anti‐CD3 mAb. Data are expressed as percentage of mean fluorescence intensity (MFI) relative to untreated cells ± SD. (b) Post‐nuclear
supernatants of T cells incubated as in (a) for 24 hr and then activated by TCR cross‐linking were processed for immunoblot, and the
phosphorylated forms of CD3ζ, PLCγ, Vav1, and Erk1/2 were revealed. A representative experiment is shown (n = 3). (c) Quantification by laser
densitometry of the protein bands. Each sample was normalised to the relative actin, and data are expressed as n‐fold between phosphorylated
proteins in anti‐CD3 stimulated samples and those in unstimulated ones (n = 3). Error bars, SD. ***p ≤ 0.001; **p ≤ 0.01; *p ≤ 0.05
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T‐cell activation.
We then moved to dissect the signalling cascade upon TCR stim-
ulation. Primary T cells were cultured as above, and after the 24‐hr
incubation, they were either left unstimulated or stimulated with
anti‐CD3 to trigger TCR activation. The phosphorylation of down-
stream signalling molecules, namely, the ζ chain of CD3 receptor, the
phospholipase C‐γ (PLCγ), the guanine nucleotide exchange factor
Vav1, and the MAP Kinase Erk1/2, was assessed by immunoblot
assay. Cells cultured with HP WT strain or with OMV WT, following
TCR stimulation, showed phosphorylation of all molecules analysedfollowing TCR stimulation. Conversely, although CD3ζ phosphoryla-
tion was maintained in T cells cultured with HP KO or OMV KO, upon
TCR stimulation, in the same cells, the downstream molecules were
not phosphorylated (Figure 2b,c). The exposure of T cells to HP1454
led to the full activation of the signalling cascade, whereas the latter
was strongly affected in cells exposed to the mutant form of the pro-
tein (Figure 2b,c), as observed for HP KO and OMV KO.
These data indicate that the absence of HP1454 negatively
impacts on the TCR signalling by impinging immediately downstream
of TCR ζ chain phosphorylation and that this regulatory activity of T‐
cell activation relies on the ITIM motif.
CAPITANI ET AL. 5 of 122.5 | HP1454 modulates the expression levels of
genes involved in T helper cell differentiation
It was previously reported that a Th1/Th17 response predominates
during persistent HP infection (D'Elios et al., 1997; Luzza et al.,
2000). In order to assess the role of HP1454 in Th cell differentiation,
primary T cells were cultured as above and analysed by real‐time poly-
merase chain reaction (PCR) for the expression of the transcription
factors c‐Maf, T‐bet, and RORγ that drive the Th2, Th1, and Th17 dif-
ferentiation, respectively. Although the expression of c‐Maf remained
the same, regardless of the stimulus, the expression levels of T‐bet and
RORγ decreased in cells cultured with HP KO and OMV KO, com-
pared with the WT counterparts, and increased in the presence of
recombinant HP1454 compared with untreated cells (Figure 3). These
results suggest that the protein HP1454 is one of the bacterial factors
required for Th1/Th17 polarisation during HP infection.2.6 | HP1454 is crucial to trigger T‐cell proliferation
upon exposure to HP
To test the effects of HP1454 on T‐cell proliferation, primary T cells
were cultured as above, loaded with the fluorescent vital dye CFSE,
and proliferation was assessed by flow cytometric analysis. TCR‐
dependent T‐cell proliferation was evaluated 72 hr after the receptor
activation (Figure 4a,b). A significant proportion of T lymphocytes
was found to proliferate, with up to three rounds of division in sam-
ples treated with either HP WT or OMV WT, as well as in the pres-
ence of the recombinant protein HP1454 WT, whereas incubation
with HP KO or OMV KO markedly affected cell proliferation
(Figure 4a,b). HP WT itself is able to inhibit T‐cell proliferation, as
expected from data previously obtained with purified HP components
(Beigier‐Bompadre et al., 2011; Boncristiano et al., 2003; Gebert,
Fischer, & Haas, 2004; Gerhard et al., 2005; Schmees et al., 2007).
However, the absence of HP1454 protein resulted in a further
decrease inT‐cell proliferation, accounting for a key role of the proteinFIGURE 3 HP1454 deficiency abrogates Th1/Th17 polarisation. T cells
Figure 2. After 24 hr, total RNA was extracted and the amount of mRNA
polymerase chain reaction. Transcript levels were normalised to the expre
determined on triplicate samples using the ΔΔCt method and expressed as
**p ≤ 0.01; *p ≤ 0.05. OMV: outer membrane vesiclesin this process. Notably, treatment of T cells with HP1454 with the
mutation in the ITIM motif resulted in a reduced cell proliferation
(Figure 4a,b).2.7 | HP1454 is required for CXCL12‐dependent
adhesion and chemotaxis in HP‐exposed T cells
Fine‐tuning of immune cell migration may be of paramount impor-
tance to the outcome of an infection (Marelli‐Berg, Cannella, Dazzi,
& Mirenda, 2008). Because the activation of Vav1, a key molecule in
the regulation of actin cytoskeleton and responsible for cell motility,
seemed to be dependent on HP1454 protein expression, we analysed
its effect on the two main steps of lymphocyte homing: adhesion and
migration (Umemoto et al., 2011). Lymphocyte adhesion to endothelial
cells mainly depends on the lymphocyte function‐associated antigen 1
(LFA‐1) and on the very late antigen 4 (VLA‐4), which interact with the
intercellular adhesion molecule 1 (ICAM‐1) and with fibronectin on the
vascular endothelium, respectively (Margadant, Charafeddine, &
Sonnenberg, 2010). In order to assess the role of HP1454 protein in
this process, we first analysed the expression levels of LFA‐1 and
VLA‐4 integrins by real‐time PCR in primary T cells purified from
peripheral blood of healthy donors, exposed to the different stimuli.
As shown in Figure 5a, the expression levels of LFA‐1 significantly
decreased in cells cultured with HP KO or OMV KO, compared with
WT counterparts, whereas no significant differences were observed
for VLA‐4 expression levels. Treatment of T cells with the recombi-
nant protein HP1454 resulted in an increase in both LFA‐1 and VLA‐
4 expression (Figure 5a). T cells treated as described were plated on
immobilised ICAM‐1, and the proportion of cells that adhered to the
substrate was determined by flow cytometry. T lymphocytes incu-
bated with either HP KO or OMV KO showed an impaired adhesion
to ICAM‐1, in marked contrast with cells cultured with HP WT or
OMV WT (Figure 5b). Interestingly, T cells stimulated with the recom-
binant HP1454 WT, as well as HP1454 mutated in the ITIM motif,
showed a strong adhesion to ICAM‐1 (Figure 5b). Taken together,purified from 10 healthy donors were cultured and activated as in
encoding c‐Maf, T‐bet, and RORγ quantified by reverse transcription
ssion level of HPRT1. The abundance of gene transcripts was
fold change of untreated T cells (dotted line; mean ± SD). ***p ≤ 0.001;
FIGURE 4 HP1454 positively regulates T‐cell proliferation. (a) Representative flow cytometric profiles of primary T cells purified from the
peripheral blood of healthy donors cultured and activated as in Figure 2, labelled with CFSE and activated by CD3 cross‐linking. (b) Percentage
of proliferatingT cells was calculated in duplicate on three independent T‐cell populations and showed as relative to untreated control (mean ± SD;
n = 3). ***p ≤ 0.001; **p ≤ 0.01. OMV: outer membrane vesicles
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FIGURE 5 HP1454 deficiency inhibits T‐cell adhesion. (a) T cells purified from 10 healthy donors were cultured as in Figure 2. After 24 hr, total
RNA was extracted and the amount of mRNA encoding LFA‐1 and VLA‐4 quantified by reverse transcription polymerase chain reaction. Transcript
levels were normalised to the expression level of HPRT1. The relative abundance of gene transcripts was determined on triplicate samples using
the ΔΔCt method and expressed as fold change of untreated T cells (dotted line; mean ± SD). (b) Quantification by flow cytometry of T cells
cultured as above, which adhered to rhICAM‐1/Fc‐coated wells upon a 10‐min exposure to 100‐ng ml−1 CXCL12. Data are expressed as
percentage of adherent cells relative to untreated control (mean ± SD; n = 6). ***p ≤ 0.001; *p ≤ 0.05. OMV: outer membrane vesicles
CAPITANI ET AL. 7 of 12these data suggest that HP1454 exerts a fundamental role in the
adhesion of T lymphocytes to endothelial cells, and such an effect is
independent from the ITIM motif.
Chemokine receptors such as C‐X‐C chemokine receptor type 4
(CXCR4), C‐C chemokine receptor type 7 (CCR7), and C‐X‐C chemo-
kine receptor type 5 (CXCR5) play a central role in lymphocyte migra-
tion (Umemoto et al., 2011). In particular, CCR7 and CXCR4 are
responsible for lymphocyte homing to secondary lymphoid organs,
whereas CXCR5 regulates B‐cell trafficking within the lymphoid organ
(Kehrl, Hwang, & Park, 2009; Pereira, Kelly, & Cyster, 2010). We
analysed the expression levels of these chemokine receptors by real‐
time PCR in T cells purified from peripheral blood of healthy donors,
cultured with the different stimuli. As shown in Figure 6a, the expres-
sion levels of CXCR4 significantly decreased in cells cultured with HPFIGURE 6 HP1454 enhances the chemotactic response to CXCL12 inT c
. After 24 hr, total RNA was extracted and the amount of mRNA encoding
polymerase chain reaction. Transcript levels were normalised to the expre
determined on triplicate samples using the ΔΔCt method and expressed a
Migration of T cells cultured as above for 24 hr, upon a 3‐hr exposure to 1
samples from each donor, are presented as migration index (ratio between
mean ± SD, n = 10). ***p ≤ 0.001; **p ≤ 0.01; *p ≤ 0.05. OMV: outer meKO or with OMV KO compared with WT counterparts, whereas for
CCR7, we observed a statistically significant decrease in expression
only in cells cultured in the presence of HP KO (Figure 6a). Neither
induction nor depression of CXCR5 expression was displayed by T
cells, regardless of the stimulus (Figure 6a). The involvement of
HP1454 in T‐cell chemotaxis was further supported by a transwell
migration assays, using CXCL12, ligand for CXCR4 receptor, as
chemoattractant. CXCR4‐dependent migration was impaired in pri-
mary T cells previously cultured with HP KO strain or with OMV
KO, with respect to cells cultured with the WT counterparts. Recom-
binant protein HP1454 WT elicited an efficient cell migration, as well
as the protein with the mutation in the ITIM domain (Figure 6b).
Hence, HP1454 acts as a positive regulator of CXCR4‐dependent T‐
cell migration, regardless of its ITIM motif.ells. (a) T cells purified from healthy donors were cultured as in Figure 2
CXCR4, CCR7, and CXCR5 were quantified by reverse transcription
ssion level of HPRT1. The relative abundance of gene transcripts was
s fold change of untreated T cells (dotted line; mean ± SD; n = 10). (b)
00‐ng ml−1 CXCL12 in a Transwell system. Data, obtained on duplicate
migrated cells in chemokine‐exposed vs. unexposed samples;
mbrane vesicles
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Both innate and acquired immune responses are elicited by HP infec-
tion. One of the most intriguing aspects of HP proteins as virulence
factors is their potential ability to modulate host‐immune response
(Amedei et al., 2006; Codolo et al., 2008; de Bernard & D'Elios,
2010). Recent studies have demonstrated the importance of HP small
proteins in diagnosis, therapy, and vaccine development (Voland,
Weeks, Vaira, Prinz, & Sachs, 2002). Among these proteins, HP1454
is a protein of 303 amino acids found in the extracellular HP milieu
(Bumann et al., 2002), whose crystal structure was defined (Quarantini
et al., 2014). Nevertheless, nothing is known about the biological func-
tions of HP1454 as well as about its impact on cells of the innate and
adaptive immunity. The present results identify T lymphocytes as a
novel cellular target of HP1454 protein. It is of note that HP1454 is
able to drive a Th1/Th17 response in vivo, in the gastric mucosa of
patients with chronic gastritis. Interestingly, in patients with gastric
adenocarcinoma, the number of HP1454‐specificT cells is significantly
higher than in uncomplicated gastritis and they maintain theTh1/Th17
profile. Thus, on the basis of these evidence, we can speculate that a
long‐lasting presence of HP in gastric mucosa might lead to a prefer-
ential Th1 and Th17 inflammation, with the contribution of HP1454,
thus paving the way for gastric oncogenesis. We have demonstrated
that HP1454 deficiency results in impaired T‐cell activation due to
the blockage of the step that couples the phosphorylation of the
TCR ζ chain with PLCγ activation. Interestingly, we mapped the
HP1454 ability to induce T‐cell activation and proliferation within its
ITIM motif, as demonstrated by the inhibitory effect on T‐cell activa-
tion obtained by applying to the cells a mutant protein with the substi-
tution of the tyrosine 286 in phenylalanine.
In infectious diseases, T helper cells orchestrate host defence
against pathogens by producing different type of cytokines. In HP
infection, a predominant activation of Th1 cells with production of
IFN‐γ occurs in vivo in the antrum (Bamford et al., 1998; D'Elios
et al., 1997; Lehmann et al., 2002; Tomita et al., 2001). In vitro stimu-
lation of T lymphocytes with the bacterial strain defective for HP1454
resulted in a prompt and remarkable downregulation of T‐bet and
RORγ transcription factors if compared with HP WT, thus suggesting
that HP1454 has a crucial role in driving the differentiation of T lym-
phocytes towards theTh1/Th17 phenotype. A number of independent
studies agree that Th1 and Th17 polarisation of HP‐specific T‐cell
response rather contribute to pathology than to host protection
(Amedei et al., 2006; Amedei et al., 2014; Bamford et al., 1998; Codolo
et al., 2008; de Bernard & D'Elios, 2010; D'Elios et al., 1997; Sommer
et al., 1998; Voland et al., 2002). Interestingly, a significant correlation
was demonstrated between disease severity and IFN‐γ secretion (de
Jonge et al., 2004; D'Elios et al., 1997; Pereira et al., 2010).
Lymphocyte trafficking is tightly controlled by chemokines and
adhesion molecules present in the lymphoid micro‐environment and
by receptors expressed by lymphocytes themselves (Kehrl et al.,
2009). In this context, we revealed the ability of HP1454 to favour
the CXCL12‐dependent migration of T lymphocytes and their adhe-
sion to ICAM‐1, thus suggesting a contribution by the protein to the
entry of T cells into lymphoid organs. This event is expected to be
followed by a robust proliferation of HP1454‐specific T cells that, inturn, would infiltrate the gastric mucosa. The impaired modulation of
T‐cell response caused by HP is thought to sustain the ongoing inflam-
matory condition and immune pathology of the stomach (Larussa,
Leone, Suraci, Imeneo, & Luzza, 2015).
Of note, we demonstrated that the HP1454‐elicited adhesion and
migration of T lymphocytes are independent from the ITIM motif, thus
suggesting that the TCR signalling only partially contributes to the cell
homing.
Altogether, our data highlight T lymphocytes as cellular targets of
HP1454 and suggest that the protein might pursue a crucial role in the
development of the severe gastric pathologies associated to the infec-
tion by HP because of its ability in amplifying the T‐cell‐dependent
inflammation.4 | EXPERIMENTAL PROCEDURES
4.1 | In silico investigation
The HP1454 protein sequence with accession number O25993 was
retrieved from the Uniprot database. Protein function recognition
was performed with the INGA (Piovesan et al., 2015), setting “data-
base all” and “String edge confidence high” as further parameters.
Sequence features were investigated with FELLS, whereas linear
motifs were identified with ELM (Dinkel et al., 2016), filtering putative
motifs falling inside structured regions. Conservation analysis was
performed with ProViz (Jehl, Manguy, Shields, Higgins, & Davey,
2016).
4.2 | Cells, antibodies, and reagents
T cells from peripheral blood of healthy donors were purified by neg-
ative selection using the RosetteSep Human T Cell enrichment Cock-
tail (StemCell Technologies), followed by density gradient
centrifugation on Lympholyte (Cedarlane Laboratories). The purity of
T‐cell population was >90%, as assessed by flow cytometry. Rabbit
polyclonal antibodies recognising the phosphorylated forms of PLCγ
(Y783), Vav1 (Y160), and Erk1/2 (T202/Y204) were purchased from
Santa Cruz Biotechnology, Invitrogen, and Cell Signaling, respectively.
Mouse monoclonal antibodies against the phosphorylated active form
of CD3ζ and against actin were from Santa Cruz Biotechnology and
Millipore, respectively, and secondary peroxidase‐labelled antibodies
from Amersham Pharmacia Biotech. FITC anti‐human CD69 was from
BioLegend; human CXCL12 and rhICAM‐1/Fc were purchased from
R&D Systems. Rabbit polyclonal custom‐made antibody against the
entire protein HP‐1454 was purchased from Agrisera.
4.3 | Bacterial strains and growth conditions
For the construction of the isogenic hp1454 mutant (HP KO), an
inverse PCR amplification of a gene library plasmid used for genome
sequencing of strain P12 (Fischer et al., 2010) was performed, using
primers WS501 (5′‐GAGGATCCATACGGGGCTATAAGCAAGG‐3′)
and WS502 (5′‐ACTAGTCGACAATAATCTTTTTCATTATTAATCCTT
AC‐3′). The PCR product, which contained thus hpp12_1432 (the
CAPITANI ET AL. 9 of 12P12 orthologue of hp1454) flanking regions and the pSMART‐HCKan
cloning vector, was digested with BamHI and SalI and subsequently
ligated with a chloramphenicol resistance cassette (to obtain plasmid
pWS420). For the generation of the isogenic mutant, the correspond-
ing plasmid was introduced by natural transformation into HP strain
P12, as described (Haas, Meyer, & van Putten, 1993). Transformants
were selected on serum agar plates containing 6‐mg L−1 chloramphen-
icol and checked for the correct replacement of hp1454 with the cat
resistance gene by sequencing.
HP strains were maintained in 5% CO2 at 37°C on Columbia agar
plates supplemented with 5% horse blood. Colonies were inoculated
into brain heart infusion broth containing 5% fetal bovine serum
(FBS) and were cultured for 2 days in rotary shaking at 180 rpm at
37°C under microaerophilic condition.4.4 | Isolation of HP OMV
HP was grown in broth culture to early stationary phase and harvested
by centrifugation for 30 min at 4,000 g at 4°C. Supernatant was fil-
tered through a 0.22‐μm cellulose acetate filter and centrifuged for
3 hr at 150,000 g at 4°C. Pellet containing vesicles was resuspended
in 500 μl of sterile PBS, adjusted to a total protein concentration of
1 μg ml−1 and stored at −80°C until use.
The absence of HP1454 both in hp1454‐deleted bacteria and in
their OMV was confirmed by western blot using a HP1454‐specific
polyclonal antibody (Figure S2B).4.5 | Heterologous overexpression and affinity
purification of HP1454 and HP1454 Y286F mutant
(HP1454 mut)
The hp1454 gene was isolated from genomic DNA of HP (strain
CCUG 17874) and cloned in pET151 plasmid as previously described
(Quarantini et al., 2014). Site‐directed mutagenesis of hp1454 gene
was performed with the QuickChange® II Site‐Directed Mutagenesis
Kit (from Agilent Technologies), using as template hp1454‐pET151
recombinant plasmid and this couple of primers: 5′‐GCATAATCTTT
CAGTTCTTTAAAAAGCAAAGATTGCAAGCGCG‐3′ and 5′‐CGCGCT
TGCAATCTTTGCTTTTTAAAGAACTGAAAGATTATGC‐3′. HP1454
and HP1454 mut were expressed in E. coli BL21 (DE3) and purified,
with slight modifications, as previously described (Quarantini et al.,
2014). Briefly, upon transformation of bacteria with the plasmids
(hp1454‐pET151 and hp1454 Y286F‐pET151), protein expression
was induced for 4 hr at 30°C by 1‐mM isopropyl‐β‐D‐thiogalactopy-
ranoside. Bacterial pellets were harvested by centrifugation and resus-
pended in 20‐mM Tris, pH 7.2, and 200‐mM NaCl and supplemented
with protease inhibitors cocktail tablet (Sigma). Lysis was carried out
by sonication. Soluble fractions were loaded onto a 1‐ml His‐trap Ni‐
NTA column (GE Healthcare) equilibrated with 20‐mM Tris, pH 7.2,
and 200‐mMNaCl; both proteins were eluted in an imidazole gradient.
Gel filtrations were performed on a Superdex 200 10/300 size‐
exclusion column. Purity of the two recombinant proteins was
assessed (Figure S3). We also ruled out the presence of
nonproteinaceous contaminants (i.e., peptidoglycans, lipoteichoic acid,and lipopolysaccharide) by testing the protein on human embryonic
kidney (HEK) 293 cells constitutively expressing TLR2/CD14
(HEK293‐TLR2/CD14) or TLR4/CD14/MD2 (HEK293‐TLR4/CD14/
MD2; Invivogen, San Diego, CA, USA).4.6 | Electron microscopy analysis and immunogold
labelling
Isolated OMV were fixed for 1 hr in 0.05% glutaraldehyde, 4% para-
formaldehyde, and 0.1‐M sodium cacodylate buffer pH 7.4, before
being embedded in L.R. White Resin (Polysciences) following manufac-
turer's instructions. Ultrathin sections were collected on nickel grids
and processed for post‐embedding immunogold labelling. After
blocking the non‐specific binding sites with 0.5% bovine serum albu-
min (BSA) in PBS for 10 min, sections were incubated with a poly-
clonal antibody against HP1454 (0.1 μg ml−1) in PBS for 30 min
followed by a 10‐nm gold conjugated goat anti‐rabbit IgG (Sigma)
diluted 1:100 in PBS for 30 min. Finally, sections were counterstained
with uranyl acetate and lead citrate and examined with a FEI Tecnai™
G2 transmission electron microscope operating at 120 kV. Images
were captured with a Veleta (Olympus Soft Imaging System) digital
camera. A negative control for staining specificity was performed by
omitting the primary antibody (Griffiths & Hoppeler, 1986; Posthuma,
Slot, & Geuze, 1987; Skepper, 2000).4.7 | Real‐time PCR analysis
Total RNA was extracted from T cells of healthy donors and
retrotranscribed as described previously (Capitani et al., 2010). Two
independent reverse transcription reactions were performed on each
RNA sample. Real‐time PCR was performed in triplicate on each cDNA
on 96‐well optical PCR plates (Sarstedt) using SSoFast EvaGreen®
SuperMix (Bio‐Rad) according to the manufacturer's instructions and
a CFX96 Real‐Time system (Bio‐Rad). After an initial denaturation
for 3 min at 95°C, denaturation in the subsequent 42 cycles was per-
formed for 10 s at 95°C, followed by 30 s of primer annealing at 60°C.
Results were processed and analysed using CFX Manager Version 1.5
software (Bio‐Rad). Transcript levels were normalised to HPRT1, used
as a housekeeping gene. Primers used for amplification are listed in
Table S1.4.8 | Generation of T‐cell clones from gastric
tumour‐infiltrating lymphocytes of the neoplastic
tissue and characterization of their cytokine profile
After approval by the local ethical committee, following informed con-
sent, gastric mucosal specimens were obtained from eight HP‐infected
patients with uncomplicated chronic gastritis (four men and four
women, mean age 66 years) and from eight HP‐infected patients with
gastric adenocarcinoma (four men and four women, mean age
68 years) and cultured for 10 days in RPMI medium 1640 supple-
mented with IL‐2 (50 U ml−1) in order to expand in vivo activated
tumour‐infiltrating lymphocytes. After disruption, single T‐cell blasts
were cloned under limiting dilution, as previously described (D'Elios
10 of 12 CAPITANI ET AL.et al., 1997). To assess their cytokine production, on antigen stimula-
tion, T‐cell blasts of each HP1454‐specific T‐cell clone (5 × 105) were
cocultured in triplicate for 48 hr in 0.5 ml of medium with 5 × 105 irra-
diated autologous antigen‐presenting cells in the absence or presence
of HP1454 (5 μg ml−1; D'Elios et al., 1997). At the end of the culture
period, duplicate samples of each supernatant were assayed for their
IFN‐γ, TNF‐α, and IL‐17 production by enzyme‐linked immunosorbent
assay (ELISA) (BioSource International).4.9 | T‐cell activation and immunoblots
Primary T cells were cultured in RPMI‐1640 (Sigma‐Aldrich) supple-
mented with 10% bovine calf serum (Hyclone) with either HP WT or
KO strains at multiplicity of infection of 100:1 for the indicated time
points, with OMV WT or OMV KO (10 μg ml−1), or with recombinant
HP1454 protein WT or HP1454 Y286F mutant (1 μg ml−1) for 24 hr.
Activation by TCR/CD3 cross‐linking was performed by incubating T
cells with the monoclonal antibody anti‐CD3 (OKT3) followed by
anti‐mouse secondary antibody, for 2 min at 37°C. Cells (5 × 106 per
sample) were lysed in 20‐mM Tris‐HCl, pH 8, 150‐mM NaCl, and 1%
Triton X‐100 plus protease inhibitors. Proteins were processed for
immunoblot, revealed by chemiluminescence (SuperSignal; West Pico
Chemiluminescent Substrate kit; Pierce Chemical), scanned by a laser
densitometer (Duoscan T2500 Agfa), and quantified with ImageQuant
5.0 software (Molecular Dynamics). Data were normalised referring to
actin, taken as loading control.4.10 | Flow cytometry
Primary T cells cultured with HP WT or HP KO, with OMV WT or
OMV KO, or with recombinant protein HP1454 WT or HP1454
Y286F mutant for 24 hr were then incubated with the anti‐human
CD69 FITC‐labelled monoclonal antibody (BioLegend). Flow cytome-
try was carried out using a Guava easyCyte cytometer (Millipore).
Data were analysed and plotted using FlowJo Version 6.1.1 software
(TreeStar). For proliferation assays, CFSE‐labelled cells (2 × 105 per
sample), cultured as previously described, were plated in 96‐well
plates and activated by CD3 cross‐linking on secondary antibody‐
coated plates as described (Boncristiano et al., 2003). Cells were
analysed 72 hr after activation.4.11 | Adhesion and chemotaxis assays
The 48‐well plates were coated o/n at 4°C with 10‐mg ml−1 rhICAM‐
1/Fc, washed with PBS, and incubated for 30 min at 37°C with RPMI
1% BSA; 2 × 105 serum‐starved T‐cells were added to each well. After
incubating 10 min at 37°C, 100‐ng ml−1 CXCL12 was added for fur-
ther 10 min. Cells that did not adhere (collected from medium and
washes) were resuspended in 0.2‐ml PBS. Cells that remained adher-
ent after three washes were harvested by 1‐min incubation with
trypsin/EDTA and washed and resuspended in 0.2‐ml PBS. Cells were
counted by flow cytometry. The percentage of adherent cells was cal-
culated as previously described (Capitani et al., 2010). Chemotaxis
assay was carried out in 24‐well Transwell chambers with 5‐μm poresize polycarbonate membranes (Corning Life Sciences) as described
previously (Patrussi et al., 2007). Filters were soaked overnight in
RPMI 1% BSA. Chemotaxis medium (500‐μl RPMI, 1% BSA) with or
without 100‐nM CXCL12 was placed in the lower chamber, and
100 μl of cell suspension (5 × 105 cells per sample) in chemotaxis
medium was placed in the upper chamber. After a 3‐hr incubation at
37°C in humidified air with 5% CO2, the upper chamber was emptied,
filters were removed, and cells in the lower chamber were counted by
flow cytometry. The migration index was calculated by determining
the ratio between migrated cells in samples exposed to CXCL12 and
those in sample not exposed to the chemokine.
4.12 | Statistical analysis
Statistical analyses were performed using Student's t test; data,
reported as the mean ± SD, were considered significant if p
values ≥ 0.05.
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